ARTICLE | Clinical News
Isolex and Isolex 300i magnetic cell selection systems regulatory update
July 12, 1999 7:00 AM UTC
The FDA granted marketing approval for NEXL’s Isolex systems to select hematopoietic stem cells and remove tumor cells from autologous peripheral blood as part of cancer therapy. NEXL said it will ins...